These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8423400)

  • 1. T- and B-cell abnormalities in systemic lupus.
    Cohen PL
    J Invest Dermatol; 1993 Jan; 100(1):69S-72S. PubMed ID: 8423400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
    Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
    Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus.
    Clough JD; Frank SA; Calabrese LH
    Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II major histocompatibility antigens and the etiology of systemic lupus erythematosus.
    Eisenberg RA; Cohen PL
    Clin Immunol Immunopathol; 1983 Oct; 29(1):1-6. PubMed ID: 6411402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.
    De Groof A; Hémon P; Mignen O; Pers JO; Wakeland EK; Renaudineau Y; Lauwerys BR
    Clin Rev Allergy Immunol; 2017 Oct; 53(2):181-197. PubMed ID: 28500565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.
    Jacob N; Stohl W
    Autoimmunity; 2010 Feb; 43(1):84-97. PubMed ID: 20014977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
    Spronk PE; Horst G; Van Der Gun BT; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1996 Jun; 104(3):446-53. PubMed ID: 9099929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.
    Singh AK
    Med Hypotheses; 1992 Dec; 39(4):356-9. PubMed ID: 1494323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP; Hendriks RW
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells in the pathogenesis of systemic lupus erythematosus.
    Hoffman RW
    Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocytes and systemic lupus erythematosus.
    Criscione LG; Pisetsky DS
    Curr Rheumatol Rep; 2003 Aug; 5(4):264-9. PubMed ID: 14531953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and control of reciprocal T-B cell diversification: implications for lupus-like autoimmunity.
    Singh RR
    Mol Immunol; 2004 Feb; 40(14-15):1137-45. PubMed ID: 15036920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of systemic autoimmunity in murine models of SLE.
    Eisenberg R
    Immunol Res; 1998; 17(1-2):41-7. PubMed ID: 9479566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.